Research News From July 13, 2011
advertisement
- Fisetin lowers methylglyoxal dependent protein glycation and limits the complications of diabetes. Free full text available in HTML and PDF formats (PDF link within full text article).
- Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial.
- Teplizumab for treatment of type 1 diabetes (Prot�g� study): 1-year results from a randomised, placebo-controlled trial.
- Predictors of associated autoimmune diseases in families with type 1 diabetes: results from the Type 1 Diabetes Genetics Consortium.
- How viral infections enhance or prevent type 1 diabetes-from mouse to man.
- C-reactive protein promotes diabetic kidney disease in a mouse model of type 1 diabetes.
- Use of a novel fluorescent glucose sensor in volunteer subjects with type 1 diabetes mellitus.
- Reduction of Postprandial Glycemic Excursions in Patients with Type 1 Diabetes: A Novel Human Insulin Formulation versus a Rapid-Acting Insulin Analog and Regular Human Insulin.
